Novel Deazaflavin Analogues Potently Inhibited Tyrosyl DNA Phosphodiesterase 2 (TDP2) and Strongly Sensitized Cancer Cells toward Treatment with Topoisomerase II (TOP2) Poison Etoposide

Abstract

Topoisomerase II (TOP2) poisons as anticancer drugs work by trapping TOP2 cleavage complexes (TOP2cc) to generate DNA damage. Repair of such damage by tyrosyl DNA phosphodiesterase 2 (TDP2) could render cancer cells resistant to TOP2 poisons. Inhibiting TDP2 thus represents an attractive mechanism-based chemosensitization approach. Currently known TDP2 inhibitors lack cellular potency and / or permeability. We report herein two novel subtypes of the deazaflavin TDP2 inhibitor core. By introducing an additional phenyl ring to the N-10 phenyl ring (subtype 11 ), or to the N-3 site of the deazaflavin scaffold (subtype 12 ) we have generated novel analogues with considerably improved biochemical potency and / or permeability. Importantly, many analogues of both subtypes, particularly compounds 11a , 11e , 12a , 12b and 12h , exhibited much stronger cancer cell sensitizing effect than the best reported previous analogue 4a toward the treatment with etoposide (ETP), suggesting that these analogues could serve as effective cellular probes.